Skip to content
DataLookout
Start free
Menu

NCT06968871

Ameliorated Pap Tests and Cervical Cancer Screening Participation

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 5 versions: 5 with changes below. See every version on ClinicalTrials.gov ↗

  1. Enrollment increased: 248 → 850 participants
  2. Eligibility criteria expanded, about 8 words Show 4 more changesShow less
    • Secondary endpoints: details revised at 2 of 4 entries
    • Study description expanded, about 26 words
    • Site contacts updated at 2 of 5 sites
    • Publications: details revised at 32 of 33 entries
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Jan 1, 2026 to Mar 1, 2026
    • Site details revised at 5 of 5 sites
    v3
  4. Start date: Aug 2025 to Jan 1, 2026v2 Show 4 more changesShow less
    • Primary completion date: Jul 2030 to Dec 31, 2030
    • Study completion date: Dec 2032 to Dec 31, 2032
    • Eligibility criteria shortened, about 17 words
    • Study description expanded, about 16 words
  5. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

3-year cervical cancer screening participation
Timeframe: 3 years

Secondary (4)

1-year cervical cancer screening participation
5-minute recalled pain intensity on a 1-5 numeric scale and a 0-10 visual analog scale
3-month recalled pain intensity on a 1-5 numeric scale and a 0-10 visual analog scale
Real time pain during the Pap test using a 1-5 numeric scale

Arms and interventions

Traditional Pap testNo intervention
Modified Pap testExperimental

Procedures: Modified Pap test

Sites

5 sites in 1 country